Effects of physical exercise on inflammation in schizophrenia
The Effects of Physical Exercise on Simple Inflammatory Markers, Systemic Immune Inflammation Index, and Systemic Immune Response Index in Patients With Schizophrenia
This study tests if regular exercise can help reduce inflammation and improve immune response in people with schizophrenia.
Quick facts
| Phase | Not applicable |
|---|---|
| Study type | Interventional |
| Enrollment | 40 (estimated) |
| Ages | 18 Years to 55 Years |
| Sex | All |
| Sponsor | Dr. Lutfi Kirdar Kartal Training and Research Hospital Government |
| Locations | 1 site (İstanbul) |
| Trial ID | NCT06574893 on ClinicalTrials.gov |
What this trial studies
This study investigates how physical exercise influences inflammation markers and immune response indices in individuals diagnosed with schizophrenia. It aims to provide insights into the potential benefits of exercise as a therapeutic intervention for mental health, particularly in psychotic disorders. The methodology involves assessing various inflammatory markers before and after a structured exercise program. The findings could enhance understanding of the relationship between physical health and mental well-being in this population.
Who should consider this trial
Good fit: Ideal candidates for this study are individuals aged 18 and older who have been diagnosed with schizophrenia according to DSM-V criteria.
Not a fit: Patients with other psychiatric diagnoses, chronic metabolic diseases, or those who are pregnant may not benefit from this study.
Why it matters
Potential benefit: If successful, this study could lead to improved mental health outcomes for patients with schizophrenia through the incorporation of physical exercise into their treatment plans.
How similar studies have performed: This approach is novel, as no other studies have specifically examined the effects of exercise on inflammation markers in patients with schizophrenia.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Individuals diagnosed with schizophrenia by a physician according to DSM-V criteria Patients treated at CMHC Individuals with schizophrenia who are 18 years of age or older Exclusion Criteria: * Those who do not consent to participate in the study Patients with a diagnosis other than schizophrenia Pregnancy Patients with chronic metabolic diseases such as diabetes, heart problems and cancer
Where this trial is running
İstanbul
- Kartal Dr Lütfi Kırdar Şehir Hastanesi — İstanbul, Turkey (Recruiting)
Study contacts
- Study coordinator: Ebru Akbuga Koc
- Email: ebru.akbuga@yeditepe.edu.tr
- Phone: 0216
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.